The Effect of Evolving Treatment Options on the Management of Multiple Myeloma

This AJMC^® Webcast recap summarizes the discussion between stakeholders about the complexities of multiple myeloma disease management as well as factors that affect medication dispensing.

Download PDF

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

The Effect of Evolving Treatment Options on the Management of Multiple Myeloma

Newsletter

Related Content

Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis

New Multiple Myeloma Therapies Offer Hope for Potential Cure: Ameet Patel, MD

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

FDA Green-Lights D-VRd Quadruplet for Newly Diagnosed Multiple Myeloma

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making

5 Things to Know About the Oral GLP-1 Era